Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease
Identifieur interne : 000522 ( PascalFrancis/Corpus ); précédent : 000521; suivant : 000523Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease
Auteurs : Daniel Weintraub ; Staci Hoops ; Judy A. Shea ; Kelly E. Lyons ; Rajesh Pahwa ; Erika D. Driver-Dunckley ; Charles H. Adler ; Marc N. Potenza ; Janis Miyasaki ; Andrew D. Siderowf ; John E. Duda ; Howard I. Hurtig ; Amy Colcher ; Stacy S. Horn ; Matthew B. Stern ; Valerie VoonSource :
- Movement disorders [ 0885-3185 ] ; 2009.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's disease (PD) exists, the aim of this study was to design and assess the psychometric properties of a self-administered screening questionnaire for ICDs and other compulsive behaviors in PD. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) has 3 sections: Section 1 assesses four ICDs (involving gambling, sexual, buying, and eating behaviors), Section 2 other compulsive behaviors (punding, hobbyism, and walkabout), and Section 3 compulsive medication use. For validation, a convenience sample of 157 PD patients at 4 movement disorders centers first completed the QUIP, and then was administered a diagnostic interview by a trained rater blinded to the QUIP results. A shortened instrument (QUIP-S) was then explored. The discriminant validity of the QUIP was high for each disorder or behavior (receiver operating characteristic area under the curve [ROC AUC]: gambling = 0.95, sexual behavior = 0.97, buying = 0.87, eating = 0.88, punding = 0.78, hobbyism = 0.93, walkabout = 0.79). On post hoc analysis, the QUIP-S ICD section had similar properties (ROC AUC: gambling = 0.95, sexual behavior = 0.96, buying = 0.87, eating = 0.88). When disorders/behaviors were combined, the sensitivity of the QUIP and QUIP-S to detect an individual with any disorder was 96 and 94%, respectively. Scores on the QUIP appear to be valid as a self-assessment screening instrument for a range of ICDs and other compulsive behaviors that occur in PD, and a shortened version may perform as well as the full version. A positive screen should be followed by a comprehensive, clinical interview to determine the range and severity of symptoms, as well as need for clinical management.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 09-0358915 INIST |
|---|---|
| ET : | Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease |
| AU : | WEINTRAUB (Daniel); HOOPS (Staci); SHEA (Judy A.); LYONS (Kelly E.); PAHWA (Rajesh); DRIVER-DUNCKLEY (Erika D.); ADLER (Charles H.); POTENZA (Marc N.); MIYASAKI (Janis); SIDEROWF (Andrew D.); DUDA (John E.); HURTIG (Howard I.); COLCHER (Amy); HORN (Stacy S.); STERN (Matthew B.); VOON (Valerie) |
| AF : | Department of Psychiatry, University of Pennsylvania/Philadelphia, Pennsylvania/Etats-Unis (1 aut., 2 aut.); Department of Neurology, University of Pennsylvania/Philadelphia, Pennsylvania/Etats-Unis (1 aut., 10 aut., 11 aut., 12 aut., 13 aut., 14 aut., 15 aut.); Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center/Philadelphia, Pennsylvania/Etats-Unis (1 aut., 11 aut., 15 aut.); Mental Illness Research, Education and Clinical Center (MIRECC), Philadelphia Veterans Affairs Medical Center/Philadelphia, Pennsylvania/Etats-Unis (1 aut.); Department of Medicine, University of Pennsylvania/Philadelphia, Pennsylvania/Etats-Unis (3 aut.); Center for Health Equity Research and Promotion (CHERP), Philadelphia Veterans Affairs Medical/Philadelphia, Pennsylvania/Etats-Unis (3 aut.); Department of Neurology, University of Kansas Medical Center/Kansas City, Kansas/Etats-Unis (4 aut., 5 aut.); Department of Neurology, Mayo Clinic Scottsdale/Scottsdale, Arizona/Etats-Unis (6 aut., 7 aut.); Department of Psychiatry, Yale University/New Haven, Connecticut/Etats-Unis (8 aut.); Division of Neurology, University of Toronto/Toronto/Canada (9 aut.); National Institute of Neurological Disorders and Stroke (NINDS)/Bethesda, Maryland/Etats-Unis (16 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 10; Pp. 1461-1467; Bibl. 31 ref. |
| LA : | Anglais |
| EA : | As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's disease (PD) exists, the aim of this study was to design and assess the psychometric properties of a self-administered screening questionnaire for ICDs and other compulsive behaviors in PD. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) has 3 sections: Section 1 assesses four ICDs (involving gambling, sexual, buying, and eating behaviors), Section 2 other compulsive behaviors (punding, hobbyism, and walkabout), and Section 3 compulsive medication use. For validation, a convenience sample of 157 PD patients at 4 movement disorders centers first completed the QUIP, and then was administered a diagnostic interview by a trained rater blinded to the QUIP results. A shortened instrument (QUIP-S) was then explored. The discriminant validity of the QUIP was high for each disorder or behavior (receiver operating characteristic area under the curve [ROC AUC]: gambling = 0.95, sexual behavior = 0.97, buying = 0.87, eating = 0.88, punding = 0.78, hobbyism = 0.93, walkabout = 0.79). On post hoc analysis, the QUIP-S ICD section had similar properties (ROC AUC: gambling = 0.95, sexual behavior = 0.96, buying = 0.87, eating = 0.88). When disorders/behaviors were combined, the sensitivity of the QUIP and QUIP-S to detect an individual with any disorder was 96 and 94%, respectively. Scores on the QUIP appear to be valid as a self-assessment screening instrument for a range of ICDs and other compulsive behaviors that occur in PD, and a shortened version may perform as well as the full version. A positive screen should be followed by a comprehensive, clinical interview to determine the range and severity of symptoms, as well as need for clinical management. |
| CC : | 002B17; 002B17G |
| FD : | Maladie de Parkinson; Trouble du contrôle des impulsions; Trouble du comportement; Jeu pathologique; Pathologie du système nerveux; Validation; Questionnaire; Dopamine |
| FG : | Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Catécholamine; Neurotransmetteur |
| ED : | Parkinson disease; Impulse control disorder; Behavioral disorder; Pathological gambling; Nervous system diseases; Validation; Questionnaire; Dopamine |
| EG : | Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Catecholamine; Neurotransmitter |
| SD : | Parkinson enfermedad; Trastorno control impulso; Trastorno conducta; Juego patológico; Sistema nervioso patología; Validación; Cuestionario; Dopamina |
| LO : | INIST-20953.354000187543670060 |
| ID : | 09-0358915 |
Links to Exploration step
Pascal:09-0358915Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease</title><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation><inist:fA14 i1="01"><s1>Department of Psychiatry, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>11 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="04"><s1>Mental Illness Research, Education and Clinical Center (MIRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hoops, Staci" sort="Hoops, Staci" uniqKey="Hoops S" first="Staci" last="Hoops">Staci Hoops</name><affiliation><inist:fA14 i1="01"><s1>Department of Psychiatry, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Shea, Judy A" sort="Shea, Judy A" uniqKey="Shea J" first="Judy A." last="Shea">Judy A. Shea</name><affiliation><inist:fA14 i1="05"><s1>Department of Medicine, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="06"><s1>Center for Health Equity Research and Promotion (CHERP), Philadelphia Veterans Affairs Medical</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lyons, Kelly E" sort="Lyons, Kelly E" uniqKey="Lyons K" first="Kelly E." last="Lyons">Kelly E. Lyons</name><affiliation><inist:fA14 i1="07"><s1>Department of Neurology, University of Kansas Medical Center</s1><s2>Kansas City, Kansas</s2><s3>USA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Pahwa, Rajesh" sort="Pahwa, Rajesh" uniqKey="Pahwa R" first="Rajesh" last="Pahwa">Rajesh Pahwa</name><affiliation><inist:fA14 i1="07"><s1>Department of Neurology, University of Kansas Medical Center</s1><s2>Kansas City, Kansas</s2><s3>USA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Driver Dunckley, Erika D" sort="Driver Dunckley, Erika D" uniqKey="Driver Dunckley E" first="Erika D." last="Driver-Dunckley">Erika D. Driver-Dunckley</name><affiliation><inist:fA14 i1="08"><s1>Department of Neurology, Mayo Clinic Scottsdale</s1><s2>Scottsdale, Arizona</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name><affiliation><inist:fA14 i1="08"><s1>Department of Neurology, Mayo Clinic Scottsdale</s1><s2>Scottsdale, Arizona</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Potenza, Marc N" sort="Potenza, Marc N" uniqKey="Potenza M" first="Marc N." last="Potenza">Marc N. Potenza</name><affiliation><inist:fA14 i1="09"><s1>Department of Psychiatry, Yale University</s1><s2>New Haven, Connecticut</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Miyasaki, Janis" sort="Miyasaki, Janis" uniqKey="Miyasaki J" first="Janis" last="Miyasaki">Janis Miyasaki</name><affiliation><inist:fA14 i1="10"><s1>Division of Neurology, University of Toronto</s1><s2>Toronto</s2><s3>CAN</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Siderowf, Andrew D" sort="Siderowf, Andrew D" uniqKey="Siderowf A" first="Andrew D." last="Siderowf">Andrew D. Siderowf</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Duda, John E" sort="Duda, John E" uniqKey="Duda J" first="John E." last="Duda">John E. Duda</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>11 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hurtig, Howard I" sort="Hurtig, Howard I" uniqKey="Hurtig H" first="Howard I." last="Hurtig">Howard I. Hurtig</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Colcher, Amy" sort="Colcher, Amy" uniqKey="Colcher A" first="Amy" last="Colcher">Amy Colcher</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Horn, Stacy S" sort="Horn, Stacy S" uniqKey="Horn S" first="Stacy S." last="Horn">Stacy S. Horn</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Stern, Matthew B" sort="Stern, Matthew B" uniqKey="Stern M" first="Matthew B." last="Stern">Matthew B. Stern</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>11 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name><affiliation><inist:fA14 i1="11"><s1>National Institute of Neurological Disorders and Stroke (NINDS)</s1><s2>Bethesda, Maryland</s2><s3>USA</s3><sZ>16 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">09-0358915</idno><date when="2009">2009</date><idno type="stanalyst">PASCAL 09-0358915 INIST</idno><idno type="RBID">Pascal:09-0358915</idno><idno type="wicri:Area/PascalFrancis/Corpus">000522</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease</title><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation><inist:fA14 i1="01"><s1>Department of Psychiatry, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>11 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="04"><s1>Mental Illness Research, Education and Clinical Center (MIRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hoops, Staci" sort="Hoops, Staci" uniqKey="Hoops S" first="Staci" last="Hoops">Staci Hoops</name><affiliation><inist:fA14 i1="01"><s1>Department of Psychiatry, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Shea, Judy A" sort="Shea, Judy A" uniqKey="Shea J" first="Judy A." last="Shea">Judy A. Shea</name><affiliation><inist:fA14 i1="05"><s1>Department of Medicine, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="06"><s1>Center for Health Equity Research and Promotion (CHERP), Philadelphia Veterans Affairs Medical</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lyons, Kelly E" sort="Lyons, Kelly E" uniqKey="Lyons K" first="Kelly E." last="Lyons">Kelly E. Lyons</name><affiliation><inist:fA14 i1="07"><s1>Department of Neurology, University of Kansas Medical Center</s1><s2>Kansas City, Kansas</s2><s3>USA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Pahwa, Rajesh" sort="Pahwa, Rajesh" uniqKey="Pahwa R" first="Rajesh" last="Pahwa">Rajesh Pahwa</name><affiliation><inist:fA14 i1="07"><s1>Department of Neurology, University of Kansas Medical Center</s1><s2>Kansas City, Kansas</s2><s3>USA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Driver Dunckley, Erika D" sort="Driver Dunckley, Erika D" uniqKey="Driver Dunckley E" first="Erika D." last="Driver-Dunckley">Erika D. Driver-Dunckley</name><affiliation><inist:fA14 i1="08"><s1>Department of Neurology, Mayo Clinic Scottsdale</s1><s2>Scottsdale, Arizona</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name><affiliation><inist:fA14 i1="08"><s1>Department of Neurology, Mayo Clinic Scottsdale</s1><s2>Scottsdale, Arizona</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Potenza, Marc N" sort="Potenza, Marc N" uniqKey="Potenza M" first="Marc N." last="Potenza">Marc N. Potenza</name><affiliation><inist:fA14 i1="09"><s1>Department of Psychiatry, Yale University</s1><s2>New Haven, Connecticut</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Miyasaki, Janis" sort="Miyasaki, Janis" uniqKey="Miyasaki J" first="Janis" last="Miyasaki">Janis Miyasaki</name><affiliation><inist:fA14 i1="10"><s1>Division of Neurology, University of Toronto</s1><s2>Toronto</s2><s3>CAN</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Siderowf, Andrew D" sort="Siderowf, Andrew D" uniqKey="Siderowf A" first="Andrew D." last="Siderowf">Andrew D. Siderowf</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Duda, John E" sort="Duda, John E" uniqKey="Duda J" first="John E." last="Duda">John E. Duda</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>11 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hurtig, Howard I" sort="Hurtig, Howard I" uniqKey="Hurtig H" first="Howard I." last="Hurtig">Howard I. Hurtig</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Colcher, Amy" sort="Colcher, Amy" uniqKey="Colcher A" first="Amy" last="Colcher">Amy Colcher</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Horn, Stacy S" sort="Horn, Stacy S" uniqKey="Horn S" first="Stacy S." last="Horn">Stacy S. Horn</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Stern, Matthew B" sort="Stern, Matthew B" uniqKey="Stern M" first="Matthew B." last="Stern">Matthew B. Stern</name><affiliation><inist:fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>11 aut.</sZ><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name><affiliation><inist:fA14 i1="11"><s1>National Institute of Neurological Disorders and Stroke (NINDS)</s1><s2>Bethesda, Maryland</s2><s3>USA</s3><sZ>16 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Behavioral disorder</term><term>Dopamine</term><term>Impulse control disorder</term><term>Nervous system diseases</term><term>Parkinson disease</term><term>Pathological gambling</term><term>Questionnaire</term><term>Validation</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term><term>Trouble du contrôle des impulsions</term><term>Trouble du comportement</term><term>Jeu pathologique</term><term>Pathologie du système nerveux</term><term>Validation</term><term>Questionnaire</term><term>Dopamine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's disease (PD) exists, the aim of this study was to design and assess the psychometric properties of a self-administered screening questionnaire for ICDs and other compulsive behaviors in PD. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) has 3 sections: Section 1 assesses four ICDs (involving gambling, sexual, buying, and eating behaviors), Section 2 other compulsive behaviors (punding, hobbyism, and walkabout), and Section 3 compulsive medication use. For validation, a convenience sample of 157 PD patients at 4 movement disorders centers first completed the QUIP, and then was administered a diagnostic interview by a trained rater blinded to the QUIP results. A shortened instrument (QUIP-S) was then explored. The discriminant validity of the QUIP was high for each disorder or behavior (receiver operating characteristic area under the curve [ROC AUC]: gambling = 0.95, sexual behavior = 0.97, buying = 0.87, eating = 0.88, punding = 0.78, hobbyism = 0.93, walkabout = 0.79). On post hoc analysis, the QUIP-S ICD section had similar properties (ROC AUC: gambling = 0.95, sexual behavior = 0.96, buying = 0.87, eating = 0.88). When disorders/behaviors were combined, the sensitivity of the QUIP and QUIP-S to detect an individual with any disorder was 96 and 94%, respectively. Scores on the QUIP appear to be valid as a self-assessment screening instrument for a range of ICDs and other compulsive behaviors that occur in PD, and a shortened version may perform as well as the full version. A positive screen should be followed by a comprehensive, clinical interview to determine the range and severity of symptoms, as well as need for clinical management.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>24</s2></fA05><fA06><s2>10</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease</s1></fA08><fA11 i1="01" i2="1"><s1>WEINTRAUB (Daniel)</s1></fA11><fA11 i1="02" i2="1"><s1>HOOPS (Staci)</s1></fA11><fA11 i1="03" i2="1"><s1>SHEA (Judy A.)</s1></fA11><fA11 i1="04" i2="1"><s1>LYONS (Kelly E.)</s1></fA11><fA11 i1="05" i2="1"><s1>PAHWA (Rajesh)</s1></fA11><fA11 i1="06" i2="1"><s1>DRIVER-DUNCKLEY (Erika D.)</s1></fA11><fA11 i1="07" i2="1"><s1>ADLER (Charles H.)</s1></fA11><fA11 i1="08" i2="1"><s1>POTENZA (Marc N.)</s1></fA11><fA11 i1="09" i2="1"><s1>MIYASAKI (Janis)</s1></fA11><fA11 i1="10" i2="1"><s1>SIDEROWF (Andrew D.)</s1></fA11><fA11 i1="11" i2="1"><s1>DUDA (John E.)</s1></fA11><fA11 i1="12" i2="1"><s1>HURTIG (Howard I.)</s1></fA11><fA11 i1="13" i2="1"><s1>COLCHER (Amy)</s1></fA11><fA11 i1="14" i2="1"><s1>HORN (Stacy S.)</s1></fA11><fA11 i1="15" i2="1"><s1>STERN (Matthew B.)</s1></fA11><fA11 i1="16" i2="1"><s1>VOON (Valerie)</s1></fA11><fA14 i1="01"><s1>Department of Psychiatry, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></fA14><fA14 i1="02"><s1>Department of Neurology, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>10 aut.</sZ><sZ>11 aut.</sZ><sZ>12 aut.</sZ><sZ>13 aut.</sZ><sZ>14 aut.</sZ><sZ>15 aut.</sZ></fA14><fA14 i1="03"><s1>Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>11 aut.</sZ><sZ>15 aut.</sZ></fA14><fA14 i1="04"><s1>Mental Illness Research, Education and Clinical Center (MIRECC), Philadelphia Veterans Affairs Medical Center</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>1 aut.</sZ></fA14><fA14 i1="05"><s1>Department of Medicine, University of Pennsylvania</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>3 aut.</sZ></fA14><fA14 i1="06"><s1>Center for Health Equity Research and Promotion (CHERP), Philadelphia Veterans Affairs Medical</s1><s2>Philadelphia, Pennsylvania</s2><s3>USA</s3><sZ>3 aut.</sZ></fA14><fA14 i1="07"><s1>Department of Neurology, University of Kansas Medical Center</s1><s2>Kansas City, Kansas</s2><s3>USA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></fA14><fA14 i1="08"><s1>Department of Neurology, Mayo Clinic Scottsdale</s1><s2>Scottsdale, Arizona</s2><s3>USA</s3><sZ>6 aut.</sZ><sZ>7 aut.</sZ></fA14><fA14 i1="09"><s1>Department of Psychiatry, Yale University</s1><s2>New Haven, Connecticut</s2><s3>USA</s3><sZ>8 aut.</sZ></fA14><fA14 i1="10"><s1>Division of Neurology, University of Toronto</s1><s2>Toronto</s2><s3>CAN</s3><sZ>9 aut.</sZ></fA14><fA14 i1="11"><s1>National Institute of Neurological Disorders and Stroke (NINDS)</s1><s2>Bethesda, Maryland</s2><s3>USA</s3><sZ>16 aut.</sZ></fA14><fA20><s1>1461-1467</s1></fA20><fA21><s1>2009</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000187543670060</s5></fA43><fA44><s0>0000</s0><s1>© 2009 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>31 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>09-0358915</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's disease (PD) exists, the aim of this study was to design and assess the psychometric properties of a self-administered screening questionnaire for ICDs and other compulsive behaviors in PD. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) has 3 sections: Section 1 assesses four ICDs (involving gambling, sexual, buying, and eating behaviors), Section 2 other compulsive behaviors (punding, hobbyism, and walkabout), and Section 3 compulsive medication use. For validation, a convenience sample of 157 PD patients at 4 movement disorders centers first completed the QUIP, and then was administered a diagnostic interview by a trained rater blinded to the QUIP results. A shortened instrument (QUIP-S) was then explored. The discriminant validity of the QUIP was high for each disorder or behavior (receiver operating characteristic area under the curve [ROC AUC]: gambling = 0.95, sexual behavior = 0.97, buying = 0.87, eating = 0.88, punding = 0.78, hobbyism = 0.93, walkabout = 0.79). On post hoc analysis, the QUIP-S ICD section had similar properties (ROC AUC: gambling = 0.95, sexual behavior = 0.96, buying = 0.87, eating = 0.88). When disorders/behaviors were combined, the sensitivity of the QUIP and QUIP-S to detect an individual with any disorder was 96 and 94%, respectively. Scores on the QUIP appear to be valid as a self-assessment screening instrument for a range of ICDs and other compulsive behaviors that occur in PD, and a shortened version may perform as well as the full version. A positive screen should be followed by a comprehensive, clinical interview to determine the range and severity of symptoms, as well as need for clinical management.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B17G</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Trouble du contrôle des impulsions</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Impulse control disorder</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Trastorno control impulso</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Trouble du comportement</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Behavioral disorder</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Trastorno conducta</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Jeu pathologique</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Pathological gambling</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Juego patológico</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>05</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Validation</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Validation</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Validación</s0><s5>09</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Questionnaire</s0><s5>10</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Questionnaire</s0><s5>10</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Cuestionario</s0><s5>10</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Dopamine</s0><s2>NK</s2><s2>FR</s2><s5>11</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Dopamine</s0><s2>NK</s2><s2>FR</s2><s5>11</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Dopamina</s0><s2>NK</s2><s2>FR</s2><s5>11</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>40</s5></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Catécholamine</s0><s5>42</s5></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Catecholamine</s0><s5>42</s5></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Catecolamina</s0><s5>42</s5></fC07><fC07 i1="06" i2="X" l="FRE"><s0>Neurotransmetteur</s0><s5>43</s5></fC07><fC07 i1="06" i2="X" l="ENG"><s0>Neurotransmitter</s0><s5>43</s5></fC07><fC07 i1="06" i2="X" l="SPA"><s0>Neurotransmisor</s0><s5>43</s5></fC07><fN21><s1>257</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 09-0358915 INIST</NO><ET>Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease</ET><AU>WEINTRAUB (Daniel); HOOPS (Staci); SHEA (Judy A.); LYONS (Kelly E.); PAHWA (Rajesh); DRIVER-DUNCKLEY (Erika D.); ADLER (Charles H.); POTENZA (Marc N.); MIYASAKI (Janis); SIDEROWF (Andrew D.); DUDA (John E.); HURTIG (Howard I.); COLCHER (Amy); HORN (Stacy S.); STERN (Matthew B.); VOON (Valerie)</AU><AF>Department of Psychiatry, University of Pennsylvania/Philadelphia, Pennsylvania/Etats-Unis (1 aut., 2 aut.); Department of Neurology, University of Pennsylvania/Philadelphia, Pennsylvania/Etats-Unis (1 aut., 10 aut., 11 aut., 12 aut., 13 aut., 14 aut., 15 aut.); Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center/Philadelphia, Pennsylvania/Etats-Unis (1 aut., 11 aut., 15 aut.); Mental Illness Research, Education and Clinical Center (MIRECC), Philadelphia Veterans Affairs Medical Center/Philadelphia, Pennsylvania/Etats-Unis (1 aut.); Department of Medicine, University of Pennsylvania/Philadelphia, Pennsylvania/Etats-Unis (3 aut.); Center for Health Equity Research and Promotion (CHERP), Philadelphia Veterans Affairs Medical/Philadelphia, Pennsylvania/Etats-Unis (3 aut.); Department of Neurology, University of Kansas Medical Center/Kansas City, Kansas/Etats-Unis (4 aut., 5 aut.); Department of Neurology, Mayo Clinic Scottsdale/Scottsdale, Arizona/Etats-Unis (6 aut., 7 aut.); Department of Psychiatry, Yale University/New Haven, Connecticut/Etats-Unis (8 aut.); Division of Neurology, University of Toronto/Toronto/Canada (9 aut.); National Institute of Neurological Disorders and Stroke (NINDS)/Bethesda, Maryland/Etats-Unis (16 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 10; Pp. 1461-1467; Bibl. 31 ref.</SO><LA>Anglais</LA><EA>As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's disease (PD) exists, the aim of this study was to design and assess the psychometric properties of a self-administered screening questionnaire for ICDs and other compulsive behaviors in PD. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) has 3 sections: Section 1 assesses four ICDs (involving gambling, sexual, buying, and eating behaviors), Section 2 other compulsive behaviors (punding, hobbyism, and walkabout), and Section 3 compulsive medication use. For validation, a convenience sample of 157 PD patients at 4 movement disorders centers first completed the QUIP, and then was administered a diagnostic interview by a trained rater blinded to the QUIP results. A shortened instrument (QUIP-S) was then explored. The discriminant validity of the QUIP was high for each disorder or behavior (receiver operating characteristic area under the curve [ROC AUC]: gambling = 0.95, sexual behavior = 0.97, buying = 0.87, eating = 0.88, punding = 0.78, hobbyism = 0.93, walkabout = 0.79). On post hoc analysis, the QUIP-S ICD section had similar properties (ROC AUC: gambling = 0.95, sexual behavior = 0.96, buying = 0.87, eating = 0.88). When disorders/behaviors were combined, the sensitivity of the QUIP and QUIP-S to detect an individual with any disorder was 96 and 94%, respectively. Scores on the QUIP appear to be valid as a self-assessment screening instrument for a range of ICDs and other compulsive behaviors that occur in PD, and a shortened version may perform as well as the full version. A positive screen should be followed by a comprehensive, clinical interview to determine the range and severity of symptoms, as well as need for clinical management.</EA><CC>002B17; 002B17G</CC><FD>Maladie de Parkinson; Trouble du contrôle des impulsions; Trouble du comportement; Jeu pathologique; Pathologie du système nerveux; Validation; Questionnaire; Dopamine</FD><FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Catécholamine; Neurotransmetteur</FG><ED>Parkinson disease; Impulse control disorder; Behavioral disorder; Pathological gambling; Nervous system diseases; Validation; Questionnaire; Dopamine</ED><EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Catecholamine; Neurotransmitter</EG><SD>Parkinson enfermedad; Trastorno control impulso; Trastorno conducta; Juego patológico; Sistema nervioso patología; Validación; Cuestionario; Dopamina</SD><LO>INIST-20953.354000187543670060</LO><ID>09-0358915</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000522 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000522 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:09-0358915
|texte= Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease
}}
| This area was generated with Dilib version V0.6.29. |  |